PaMeLa, Inc. is developing an AI and big data system that scores pain from EEG signals without relying on patients' verbal reports.
Based in Osaka, Japan and established in 2016, PaMeLa, Inc. is building a system that evaluates pain without taking verbal information from patients. Pain components are selected from a large pain dataset using big data analysis and artificial intelligence, and the pain score is determined by EEG. The company has received grants and venture funding every year since its establishment. It is working on a device that is easy to put on and take off and is about the size of a small electroencephalograph.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in